TECNALIA and the University of the Basque Country’s 3D bioprinter wins an award

TECNALIA and the University of the Basque Country’s 3D bioprinter given an award by medical news outlets Diario Médico and Correo Farmacéutico

• Diario Médico and Correo Farmacéutico have just held the 3rd Ennova Health 2023 Awards, which recognise the work of professionals, institutions and companies whose digital initiatives have added value, contributed to the sustainability of the system and improved patients’ lives throughout 2022/23
• The 3D Bioprinters project by TECNALIA and the University of the Basque Country, which has already created its first medicines and biological prototypes, won the award in the category of Digital Empowerment of Patients

21 November 2023. The 3D Bioprinting project developed by the research and technological development centre TECNALIA and the University of the Basque Country UPV/EHU has been recognised by medical news outlets Diario Médico and Correo Farmacéutico and the innovation and health awards they present annually, in the category of Digital Empowerment of Patients.

The award was given last night at the 3rd Ennova Health 2023 Awards, which recognise the work of professionals, institutions and companies whose digital initiatives have added value, contributed to the sustainability of the system and improved patients’ lives throughout 2022/23.

The bioprinting centre, which has already created its first medicines and biological prototypes, will enable the development of personalised therapies, especially in paediatrics, healthy ageing and regenerative medicine and tissue engineering, serving the pharmaceutical industry and the healthcare sector.

Eider Larrarte, Director of TECNALIA’s pharmaceutical laboratories, thanked the organisation for the award and explained that “3D printing paves the way for personalised medicine in special situations and for small groups of patients who cannot be treated with traditional, commercially available pharmaceutical forms”. This bioprinter puts patients’ needs first and will help to improve the quality of life of all these people”.

She also highlighted the “fantastic work carried out jointly by researchers, because thanks to your effort and creativity, we are helping to create a better world with innovation and technology as our allies”.

This project is supported by the Provincial Council of Alava, and Throughout this year and 2024, researchers will focus on the experimental phase and evolution of the software and machine intelligence, with the aim of enabling hospitals and pharmacy units to have bioprinters for the manufacture of printed matter and biostructures.

About TECNALIA

TECNALIA is the largest applied research and technological development centre in Spain, a European benchmark and member of the Basque Research and Technology Alliance.

TECNALIA works with companies and institutions to improve their competitiveness, people's quality of life and achieve sustainable growth, thanks to a team of more than 1,500 people committed to building a better world through technological research and innovation.

This is why TECNALIA's research has a real impact on society and generates benefits in the form of quality of life and progress.  Its main areas of action are: smart manufacturing, digital transformation, energy transition, sustainable mobility, health and food, urban ecosystem and circular economy.

In the latest brand awareness and positioning study carried out by the European Research Survey (ERS) in 2022, TECNALIA tops the list regarding R&D and Innovation brand awareness.

About UPV/EHU

The University of the Basque Country is ranked among the Top 500 universities in the world, according to the Shanghai ranking. It has over 43,000 graduate and post-graduate students, and employs more than 7,400 people in higher education, research and transfer. It is the main research actor in the Basque Country.